South Korea
· Delayed Price · Currency is KRW Gencurix Statistics
Total Valuation
Gencurix has a market cap or net worth of KRW 29.18 billion. The enterprise value is 37.12 billion.
| Market Cap | 29.18B |
| Enterprise Value | 37.12B |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Gencurix has 15.24 million shares outstanding. The number of shares has increased by 49.48% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 15.24M |
| Shares Change (YoY) | +49.48% |
| Shares Change (QoQ) | +1.44% |
| Owned by Insiders (%) | 15.28% |
| Owned by Institutions (%) | 7.46% |
| Float | 11.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.11 |
| PB Ratio | 2.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.61 |
| EV / Sales | 12.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.28 |
Financial Position
The company has a current ratio of 0.22, with a Debt / Equity ratio of 1.25.
| Current Ratio | 0.22 |
| Quick Ratio | 0.15 |
| Debt / Equity | 1.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.95 |
| Interest Coverage | -17.01 |
Financial Efficiency
Return on equity (ROE) is -112.87% and return on invested capital (ROIC) is -26.91%.
| Return on Equity (ROE) | -112.87% |
| Return on Assets (ROA) | -23.43% |
| Return on Capital (ROIC) | -26.91% |
| Revenue Per Employee | 42.24M |
| Profits Per Employee | -206.48M |
| Employee Count | 69 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 1.70 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.36% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -73.36% |
| 50-Day Moving Average | 2,517.26 |
| 200-Day Moving Average | 3,195.62 |
| Relative Strength Index (RSI) | 27.62 |
| Average Volume (20 Days) | 94,810 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gencurix had revenue of KRW 2.91 billion and -14.25 billion in losses. Loss per share was -1,027.60.
| Revenue | 2.91B |
| Gross Profit | 1.71B |
| Operating Income | -11.42B |
| Pretax Income | -15.13B |
| Net Income | -14.25B |
| EBITDA | -10.00B |
| EBIT | -11.42B |
| Loss Per Share | -1,027.60 |
Balance Sheet
The company has 773.79 million in cash and 10.75 billion in debt, giving a net cash position of -9.97 billion or -654.29 per share.
| Cash & Cash Equivalents | 773.79M |
| Total Debt | 10.75B |
| Net Cash | -9.97B |
| Net Cash Per Share | -654.29 |
| Equity (Book Value) | 8.57B |
| Book Value Per Share | 733.76 |
| Working Capital | -10.06B |
Cash Flow
In the last 12 months, operating cash flow was -9.26 billion and capital expenditures -2.05 billion, giving a free cash flow of -11.31 billion.
| Operating Cash Flow | -9.26B |
| Capital Expenditures | -2.05B |
| Free Cash Flow | -11.31B |
| FCF Per Share | -741.62 |
Margins
| Gross Margin | 58.76% |
| Operating Margin | -391.78% |
| Pretax Margin | -519.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -387.92% |
Dividends & Yields
Gencurix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.48% |
| Shareholder Yield | -49.48% |
| Earnings Yield | -53.69% |
| FCF Yield | -38.75% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Gencurix has an Altman Z-Score of -4.95. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.95 |
| Piotroski F-Score | n/a |